Trial · NCT05192382
Participant flow21
How many started, completed or left each group, period by period.
1 to 20 of 21
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| RC Phase (Up to Week 24) | STARTED | RC: Paltusotine Then OLE | 54 | |
| RC Phase (Up to Week 24) | STARTED | RC: Placebo Then OLE | 57 | |
| RC Phase (Up to Week 24) | STARTED | Direct to OLE: Paltusotine | 0 | |
| RC Phase (Up to Week 24) | COMPLETED | RC: Paltusotine Then OLE | 52 | |
| RC Phase (Up to Week 24) | COMPLETED | RC: Placebo Then OLE | 54 | |
| RC Phase (Up to Week 24) | COMPLETED | Direct to OLE: Paltusotine | 0 | |
| RC Phase (Up to Week 24) | NOT COMPLETED | RC: Paltusotine Then OLE | 2 | |
| RC Phase (Up to Week 24) | NOT COMPLETED | RC: Placebo Then OLE | 3 | |
| RC Phase (Up to Week 24) | NOT COMPLETED | Direct to OLE: Paltusotine | 0 | |
| OLE Phase (Up to Week 200) | STARTED | RC: Paltusotine Then OLE | 50 | |
| OLE Phase (Up to Week 200) | STARTED | RC: Placebo Then OLE | 52 | |
| OLE Phase (Up to Week 200) | STARTED | Direct to OLE: Paltusotine | 11 | |
| OLE Phase (Up to Week 200) | Ongoing | RC: Paltusotine Then OLE | 49 | |
| OLE Phase (Up to Week 200) | Ongoing | RC: Placebo Then OLE | 48 | |
| OLE Phase (Up to Week 200) | Ongoing | Direct to OLE: Paltusotine | 10 | |
| OLE Phase (Up to Week 200) | COMPLETED | RC: Paltusotine Then OLE | 0 | |
| OLE Phase (Up to Week 200) | COMPLETED | RC: Placebo Then OLE | 0 | |
| OLE Phase (Up to Week 200) | COMPLETED | Direct to OLE: Paltusotine | 0 | |
| OLE Phase (Up to Week 200) | NOT COMPLETED | RC: Paltusotine Then OLE | 50 | |
| OLE Phase (Up to Week 200) | NOT COMPLETED | RC: Placebo Then OLE | 52 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05192382/flow